当前位置:首页 - 行情中心 - 海特生物(300683) - 财务分析 - 现金流量表

海特生物

(300683)

  

流通市值:32.02亿  总市值:34.29亿
流通股本:1.22亿   总股本:1.31亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金234,374,737.41113,179,980.17503,810,380.48372,277,047.5
  收到的税费返还67,140.1850,436.21139,833.2130,782.37
  收到其他与经营活动有关的现金13,749,169.5612,024,503.1127,292,446.320,121,993.43
  经营活动现金流入小计248,191,047.15125,254,919.49531,242,659.98392,529,823.3
  购买商品、接受劳务支付的现金79,577,590.5839,149,683.02167,070,193.01119,501,849.05
  支付给职工以及为职工支付的现金94,770,962.6351,931,007.84241,653,525.31199,457,004.73
  支付的各项税费17,123,853.697,483,458.2423,619,536.3918,997,071.78
  支付其他与经营活动有关的现金59,593,350.4429,202,743.57175,437,382.05130,614,231.42
  经营活动现金流出小计251,065,757.34127,766,892.67607,780,636.76468,570,156.98
  经营活动产生的现金流量净额-2,874,710.19-2,511,973.18-76,537,976.78-76,040,333.68
二、投资活动产生的现金流量:
  收回投资收到的现金416,715,903.57278,115,903.571,635,396,794.52904,650,000
  取得投资收益收到的现金1,891,986.51,584,382.112,848,345.094,097,617.37
  处置固定资产、无形资产和其他长期资产收回的现金净额564,385.71483,7001,369,673.51473,473.51
  投资活动现金流入小计419,172,275.78280,183,985.671,649,614,813.12909,221,090.88
  购建固定资产、无形资产和其他长期资产支付的现金19,609,071.5511,928,736.7150,535,918.5747,579,526.34
  投资支付的现金840,693,589.87646,503,455.51,265,187,978.38973,800,000
  支付其他与投资活动有关的现金--971,643.539,759,621.88
  投资活动现金流出小计860,302,661.42658,432,192.211,316,695,540.451,061,139,148.22
  投资活动产生的现金流量净额-441,130,385.64-378,248,206.54332,919,272.67-151,918,057.34
三、筹资活动产生的现金流量:
  吸收投资收到的现金--4,000,0004,000,000
  其中:子公司吸收少数股东投资收到的现金--4,000,000-
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--4,000,0004,000,000
  偿还债务支付的现金163,658.371,003,139.424,964,789.884,075,491.53
  分配股利、利润或偿付利息支付的现金1,948,732.65-17,869,627.7117,691,935.39
  支付其他与筹资活动有关的现金4,348,431.044,170,431.048,421,5053,861,732.66
  筹资活动现金流出小计6,460,822.065,173,570.4631,255,922.5925,629,159.58
  筹资活动产生的现金流量净额-6,460,822.06-5,173,570.46-27,255,922.59-21,629,159.58
四、汇率变动对现金及现金等价物的影响-26,073.92-14,826.84-3,164.261,699.94
五、现金及现金等价物净增加额-450,491,991.81-385,948,577.02229,122,209.04-249,585,850.66
  加:期初现金及现金等价物余额648,242,569.6648,242,569.6419,120,360.56419,120,360.56
  期末现金及现金等价物余额197,750,577.79262,293,992.58648,242,569.6169,534,509.9
补充资料:
  净利润-79,888,350.24--235,430,201.19-
  资产减值准备4,764,842.38-124,202,306.5-
  固定资产和投资性房地产折旧31,293,256.59-68,204,958.96-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧31,293,256.59-68,204,958.96-
  无形资产摊销12,397,046.46-25,565,530-
  长期待摊费用摊销718,077.82-2,490,095.9-
  处置固定资产、无形资产和其他长期资产的损失2,301,165.53-979,179.5-
  固定资产报废损失513,979.84-233,444.38-
  公允价值变动损失-1,108,216.31-12,521,343.58-
  财务费用525,151.83-1,390,342.84-
  投资损失1,865,475.3--20,643,544.25-
  递延所得税-7,411,986.58--3,965,614.84-
  其中:递延所得税资产减少-6,519,738.26--582,897.47-
    递延所得税负债增加-892,248.32--3,382,717.37-
  存货的减少-2,116,241.43-12,378,341.24-
  经营性应收项目的减少1,224,963.08--8,709,997.93-
  经营性应付项目的增加31,490,283.11--59,329,889.96-
  现金的期末余额197,750,577.79-648,242,569.6-
  减:现金的期初余额648,242,569.6-419,120,360.56-
  现金及现金等价物的净增加额-450,491,991.81-229,122,209.04-
公告日期2026-08-242026-04-242026-04-242025-10-23
审计意见(境内)标准无保留意见
TOP↑